Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David MacDonald

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
BMJ Supportive & Palliative Care|November 3, 2025
Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyYvan Beaussant, Zachary Sager, Caitlin Brennan, et al.
Blood|March 5, 2014
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT studyIan W Flinn, Richard van der Jagt, Brad S Kahl, et al.
The New England Journal of Medicine|June 2, 2018
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, et al.
Arthritis Care & Research|September 29, 2015
Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health StudyMurray Baron, Marie Hudson, Marie Dagenais, et al.
Journal of the National Cancer Institute|April 15, 2015
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12Matthew C Cheung, Annette E Hay, Michael Crump, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 12, 2015
The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general populationMarie Dagenais, David MacDonald, Murray Baron, et al.
Future Oncology (London, England)|June 19, 2025
Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphomaNancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell LymphomaNancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.
Bioscience|March 31, 2018
International Wildlife Law: Understanding and Enhancing Its Role in ConservationArie Trouwborst, Andrew Blackmore, Luigi Boitani, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
The Lancet. Oncology|May 5, 2012
Phase 2 trial design in neuro-oncology revisited: a report from the RANO groupEvanthia Galanis, Wenting Wu, Timothy Cloughesy, et al.
BMJ Supportive & Palliative Care|November 3, 2025
Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacyYvan Beaussant, Zachary Sager, Caitlin Brennan, et al.
Blood|March 5, 2014
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT studyIan W Flinn, Richard van der Jagt, Brad S Kahl, et al.
The New England Journal of Medicine|June 2, 2018
Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström's MacroglobulinemiaMeletios A Dimopoulos, Alessandra Tedeschi, Judith Trotman, et al.
Arthritis Care & Research|September 29, 2015
Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health StudyMurray Baron, Marie Hudson, Marie Dagenais, et al.
Journal of the National Cancer Institute|April 15, 2015
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12Matthew C Cheung, Annette E Hay, Michael Crump, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 12, 2015
The Canadian Systemic Sclerosis Oral Health Study IV: oral radiographic manifestations in systemic sclerosis compared with the general populationMarie Dagenais, David MacDonald, Murray Baron, et al.
Future Oncology (London, England)|June 19, 2025
Plain language summary of the ECHELON-3 study: brentuximab vedotin combination treatment in people with diffuse large B-cell lymphomaNancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell LymphomaNancy L Bartlett, Uwe Hahn, Won-Seog Kim, et al.
Bioscience|March 31, 2018
International Wildlife Law: Understanding and Enhancing Its Role in ConservationArie Trouwborst, Andrew Blackmore, Luigi Boitani, et al.
Pageof 15